chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I received my Pfizer booster for COVID-19 on 10/1/2021. On 8/30/2022, I had a dry cough the entire day. On 8/31/2022, I woke up with a splitting headache. I also still had the cough from the day before. I took a home test for COVID-19 that day and got a negative result. I'm a counselor, and even though I felt bad, I still saw three of my clients via online platform. However, I ended up cancelling the rest of the appointments for that day on account of my feeling ill. On 9/1/2022, I felt worse. I took another home test that day and got a positive result. I had a fever of 102 for pretty much the whole day. I took TYLENOL, which helped bring the temperature down, but it always shot back up when the medicine wore off. I had body aches, and the splitting headache was the worst symptom. My neck also ached. I didn't get much sleep those nights, because I was miserable and uncomfortable. At one point, I lost my senses of taste and smell. I completely lacked an appetite and felt nauseous. I ate very little. I didn't really throw up much; I had dry heaves more than anything. I also had nasal congestion. I went to get monoclonal antibodies on 9/2/2022, but when I got to the infusion center, they discovered that my blood pressure was 85/50 or thereabouts. I was then wheeled to the ER and treated for low BP. I ended up staying practically the entire day at the ER and didn't get the monoclonal antibodies until 9/6/2022. After I received the antibodies, I didn't ache as much, and my temperature was lower. However, I still lacked a sense of taste and smell, lacked an appetite, and felt extremely fatigued. I spent most of my time on the sofa or in bed. I gradually felt a little better, but I became easily fatigued if I tried to do anything. I ended up being out of work for 2 weeks as a result. After those 2 weeks were up, I began easing back into my work again. Before COVID-19, I normally saw 6-8 clients per day. However, when I first started working again, I could only see about 3 before I became too exhausted to see any more. At the time of this writing, I'm still not exactly back to my pre-COVID energy levels. I saw 6 clients the other day, and before the end of the day, I was absolutely wiped out. Whenever I walk my dog, I sometimes get a little winded after walking at a normal speed. I'm normally not a high-energy person, though before I got COVID-19, I was able to walk on the treadmill for about 30 minutes, but I can't even do that now. If I'm resting, I don't have shortness of breath. I only have shortness of breath whenever I'm moving. At the time of this writing, I have regained my sense of taste. However, it's not what it was before I got COVID-19. These days, coffee just doesn't taste the same as it used to. I have also regained my sense of smell; as far as I know, everything is fine in that area. During my bout with COVID-19, I began getting a strange sensation in my right leg. I sometimes would have a tingling or numb sensation that extended from above my knee to about 12 inches above the knee on the ventral surface of the leg. It still comes intermittently. At this point, I would say that I have mostly recovered from my symptoms, but not 100%.
Adverse effects begin the day after injection. Feeling very unfocused, chills, sweats, ached all over, nauseous, felt lighted headed, very fatigued and went from sleep to awake every half hour. These symptoms continued for a week then slowly get better. One week from injection my arm became very sore and covered with rash at injection site.  Within the next 2 days I was covered with a rash.  I am still feeling very unfocused and fatigued as I write this on March 17, 2021. I chose not to have the 2nd dose as I am very concerned of having a worse reaction.  I did not ever have breathing difficulties or a fever.
Non-occlusive acute DVT in the left popliteal vein. Occlusive acute DVT in the left peroneal vein. Superficial vein thrombosis in the left great saphenous vein. Positive for DVT in the left Lower extremity.
sick for weeks; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via Social media and transmitted to Sanofi on 19-Nov-2020.  This case involved patient of an unknown age who was sick for weeks (illness), while he/she received vaccine INFLUENZA VACCINE.  The patient's medical history, medical treatments, vaccinations, concomitant medications and family history were not provided.   On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE (produced by unknown manufacturer) (lot number unknown) via an unknown route in an unknown administration site for prophylactic vaccination.  On an unknown date, the patient was sick for weeks (illness) (Unknown latency) following the administration of INFLUENZA VACCINE. That was the last flu shot patient had ever got. He/she Will not get another.  No relevant laboratory tests were reported.  It was not reported if the patient received a corrective treatment.  Event outcome was reported as Unknown for illness.  There will be no information regarding the batch number for the case.
sick-Temp 101.5, severe H/A, photophobic-seen in ER negative CT, LP, CXR, CBC. Blood culture pending. Fatigue now, sore swollen (R) arm Felt bad 2 hr after shot, seen in ER 8:30 A 9/29/07 still sore neck
Had a bleeding on the rectum, GI bleeding; Had a bleeding on the rectum, GI bleeding; This is a spontaneous report from a contactable consumer (patient) via a Pfizer Sponsored Program. A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunization and received second dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as DOSE 2, SINGLE for covid-19 immunization. The patient's medical history and concomitant medications was not reported. On an unspecified date the patient reported she had a bleeding on the rectum, GI bleeding. She was supposed to get the booster dose as well and she has a question regarding the booster dose. The outcome of the events was reported as unknown.  This lot number for the vaccine, [BNT162B2] was not provided and will be requested during follow-up.
Pt received her 1st round of 4 shots at 10 weeks of age and within 96 hours, she started to have seizures and was hospitalized for 4 days. Seizures continued and she was placed on phenobarbital at 5 months old. She received her 2nd set of shots and within 96 hours, had even worse seizures and had prolonged hospitalization. Erythematous papular rash on chest/face. Pt was expected to die before her 1st birthday. She now is almost 3 (Thank God) she still suffers from a seizure disorder. Currently cannot sit, walk, or talk has been diagnosed legally blind. To the medical field, she still remains undiagnosed, but is making great improvement everybody. Thank to the good Lord. I would like to see doctorsno administer so many shots at once- go back to 2 at a time. I believe they don't want to admit this was Pt's problem, but her adverse effect both times was within 3-4 days of her shots prior too. She was developements normal. She never should have received her 2 round... More education.
No additional adverse events reported; improperly stored vaccines may have been administered to patients; This spontaneous report has been received from a nurse, referring to a patient of unknown gender and age. Information about the patient's pertinent medical history, concurrent conditions, and previous drugs reactions or allergies were not provided.  On 17-DEC-2019, the patient was vaccinated with an improperly stored (product storage error) hepatitis a vaccine, inactivated (VAQTA), (Therapy type: Digital Data Logger), lot number S025258 and expiration date 05-NOV-2020 for prophylaxis (strength, dose, dose number, frequency, route of administration, and anatomical location, were not provided).  The vaccine was stored at a temperature above 47 degree Fahrenheit (47.1 Fahrenheit), for a timeframe of 8 to 16 minutes, with no previous temperature excursion. The call was due to a Digital Data Logger.  No additional adverse events were reported.  This case is one of several cases from the same reporter.; Sender's Comments:  US-009507513-2001USA009007:
ABOUT 30 MINUTES AFTER RECEIVING FIRST DOSE OF HEP B, EMPLOYEE BACAME SWEATY, WEAK AND LETHARGIC. WAS SENT TO ER FOR EVAL. WAS RECOMMENED NOT TO RECEIVE ANY MORE DOSES OF HEP B VACCINE BY ER DOCTOR.
Knot @ injection site, followed by excessive swelling between shoulder - elbow. Severe muscle ache/stiffness. Incessant heavy urination, and severe heartburn, x5 day duration
Pt. had dizziness, then LOC x 1-2 inches after GARDASIL. Pt. recovered after the provider's help.
Information has been received from a health professional concerning a 13 month old 25 lb. 13 oz. 33 1/2 inch male with an allergy to OMNICEF who on 24-OCT-2007 at 11:30 hours received his first subcutaneous dose in the right of ProQuad (Oka/Merck upgrade process) (lot#658314/0774U). Concomitant vaccinations included a first intramuscular dose in the left of Fluzone (lot#U2493AA) and a fourth intramuscular dose in Hib (unspecified carrier (lot# UF204PC). Illness reported at the time of vaccination included being fussy and a slight cough not accompanied by fever for 2 to 3 days. No adverse events were reported following prior vaccination. It was reported that on 31-OCT-2007, he was seen in the office by the physician after on 28-OCT-2007 he developed a rash that started on his face, and after 4 days new ones developed and spread. It was reported that the patient developed greater than 100 lesions that were diffuse papules with few tiny vesicles on a red base on the patient's trunk, face and extremities. It was reported that the patient was not ill, no fever and was pleasant. No diagnostic tests were reported. Current patient status was not reported. Additional information has been requested.
Information has been received on 20 Sep 2001 from a licensed practical nurse concerning a male (age unspecified) with no known allergies who "one month ago" was vaccinated with a first dose of hepatitis b vaccine recombinant (yeast). The patient had hot flushing and malaise post vaccination. There was no other information. The patient sought unspecified medical attention. Follow-up information indicated that when the patient arrived at the community occupational health center for his second dose of hepatitis b vaccine recombinant (yeast) it was not administered. It was noted that the patient has since quit his job. No further information is available.
About 10-15 minutes after receiving the H1N1 vaccine I went temporarily blind. I was tired and realized I couldn't see. I thought I didn't have my eyes open, so I waved my hand in front of my face and realized I couldn't see any light movement at all. I told my father who was driving, and he turned around and took me back to the vaccine administration site.  We arrived back at the site about 20-25 minutes after my injection. I remember they took my temperature and my blood pressure, they may have checked my O2 levels but I'm not certain. They asked me questions about my sight, what I could see. Eventually, I started being able to see light again and could make out shadows. I believe this was about 40-50 minutes after my injection, my vision started coming back slowly, and when it fully returned they had my dad take me home.
No adverse events noted. Patient was inadvertently vaccinated with both PEDIARIX and IPOL.
Weakness of legs, upper extremity, facial weakness rash all over body - was diagnosed with GB syndrome and hospitalized for IVIG and LP 7/25/07-records received -DX: Guillain Barre. Day before admission 5/18/07-developed macular papular rash on face and headache pain in both legs, shortness of breath. Admitted on 5/19/07-  Unsuccessful spinal tap. Treated with IVIG and there was no progressive loss of muscle tone no loss of sensation. Good muscle tone
It felt like I had a bad cold when I tested positive. I had mainly a runny nose with a cough. I also had a low temperature.
Pneumonia; Sepsis; Aggravated an infection; Fever (104 ° F); Chills very bad; A spontaneous report was received from a consumer concerning her husband, 44-year-old, male patient who developed pneumonia, sepsis, aggravated an infection/infection, fever (104°F)/pyrexia, chills very bad/chills.  The patient's medical history included diabetes type 2, lung infection and blood pressure. Products known to have been used by the patient, within two weeks prior to the event, included Amlodipine.   On 13 Jan 2021, the patient received their second of two planned doses of mRNA-1273 (Batch number: unknown) at unknown injection site for prophylaxis of COVID-19 infection.    On 13 Mar 2021 the patient five minutes later after received second dose he started to had chills very bad and fever (104 ° F). The patient has pneumonia and sepsis. This aggravated an infection that he had in a lung 11 years ago (before receiving the vaccine they were thinking of amputating a leg, because he also has type 2 diabetes). The patient was under treatment, every week to avoid amputation but now they decided to amputate his leg as soon as possible due to the infection. Treatment information of the event was not provided.  Action taken with mRNA-1273 in response to the event(s) was not provided.  The outcome of the event(s) pneumonia, sepsis, aggravated an infection, fever (104°F), chills very bad was not reported.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of these event, a causal relationship cannot be excluded.
Double pneumonia with blood clots in lungs.  Sepsis.  Extremely low oxygen levels in blood.  Extremely low blood pressure.  Rapid breathing - over 60 per minute.  5-day ICU stay at Hospital.   Death.
Information has been received from a registered nurse concerning a 16 year old female patient, who on an unspecified date inadvertently received a dose of PROQUAD (Merck) (Lot # not provided) instead of VARIVAX (Merck). It was unspecified if the patient sought medical attention. No adverse effect was reported. Additional information has been requested.
No other AE information given at this time; HCP calling to report patient was given PNEUMOV AX 23 that was recalled; This spontaneous report was received from a medical assistant referring to a patient of unknown age and gender. Information about patient's pertinent concurrent conditions, medical history, concomitant medications and previous drug reactions or allergies were not provided.  On 14-OCT-2020, the patient was vaccinated with pneumococcal vaccine, polyvalent (23-valent)(PNEUMOVAX23) which was recalled at a dose of 0.5 milliliter as prophylaxis (concentration, number of administered dose, route and anatomical location of administration; lot # S036495, expiration date reported 13-SEP-2021) (recalled product administered). No adverse events were reported. combinationproductreport: Yes; brandname: PNEUMOVAX23 SYRINGE (DEVICE); commondevicename: Pneumococcal Vaccine, Polyvalent (23-valent); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S036495; expirationdate: 13-SEP-2021; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not meet the criteria for Reportability
2 inch diameter red rash with 1/4 inch by 1/2 inch hard spot in center and Hot to touch
Vertigo upon rising in the morning.  Sitting or standing caused vomiting.  Transported by ambulance to ER.  Cause was uncertain but dehydration was a possibility.  Prior to vertigo, I experienced tinnitus shortly after the 2nd COVID injection.  Did not relate to injection at the time so was not reported.  Neither tinnitus or vertigo was experienced at any time prior to the injection.   Vertigo has not reappeared but tinnitus continues 24 hours a day.
This spontaneous report as received from a pharmacy technician refers to a 1 year old patient of unknown gender. Patient's concurrent conditions, medical history, concomitant medications, drug reactions and allergies were not reported. On 23-FEB-2018, the patient was vaccinated with improperly stored dose of VARIVAX (lot # N022979, expiry 23-AUG-2019) for prophylaxis. No adverse effect was reported. The VARIVAX temperature excursion occurred on 14-DEC-2017 and 30-DEC-2017. On 14-DEC-2017, the vaccine was exposed to the temperature of 16.9 degree Fahrenheit (F) for 30 minutes. On 30-DEC-2017, the vaccine was exposed to the temperature of 6 degree Fahrenheit (F) to 14 degree F for 30 minutes. It was reported that the event was because of data logger. No product quality complaint was involved. This is one of the several reports received from the same reporter source.; Sender's Comments: US-009507513-1802USA001558:
Elevated pulse over 100.  It occurred immediately after shot (according to fitbit), but thought it was just because I was nervous.  However, it persisted throughout the day.  Typically when I was up and moving.  However, usually in low 90s when just up and moving.  I cross 100 when I'm doing yard work or doing light exercise.  Last night when going to bed I was in lower 80s, when usually I'm in lower 70s upper 60s at bed time.  Today, I haven't crossed 100 as much, but have been taking it easy.
Seriousness Criteria: Other-Medically Significant Initial report received from a health professional on 08 November 2007. A patient (age and gender not reported) received Fluzone (Lot number, administration date and route/site not reported) and developed a possible nerve problem in that limb (onset date not reported). No additional information had been provided at the time of this report.
This spontaneous report as received from a doctor of pharmacy refers to a 46 years old female patient with no pertinent medical history and no drug reactions/allergies who nine years ago "in 2003" was vaccinated with the first dose of PNEUMOVAX23 (route and lot# not reported). On 13-SEP-2012, the patient received a booster IM in upper left arm 0.5 ml dose of PNEUMOVAX23 (lot# H013581, exp date: 03-MAR-2014). No other co-suspects were reported. There were no concomitant medications reported. It was reported that on 14-SEP-2012, the patient experienced redness and pain from the injection site to the elbow. The patient did not receive treatment and did not have lab diagnostics studies performed. At the time of the report, the patient had not recovered, the patient contacted the pharmacist. The relatedness for redness from the injection site to the elbow and pain from the injection to the elbow was unknown for PNEUMOVAX23. Additional information is not expected.
After the vaccine was administered, the patient went to the front of the store to stay in line, the patient became dizzy, pale and trembled. She did not wait sitting. Patient was seated alcohol was provided to inhale, gave her something to drink. BP 112/60 patient recovered after a few minutes.
One small blister and One large blister that kept growing; it s about a size of a nickel; it s sore; Little red; It's was bleeding; The small blister burst out; This spontaneous case was reported by a consumer and describes the occurrence of BLISTER (One small blister and One large blister that kept growing), BLISTER RUPTURE (The small blister burst out), VACCINATION SITE HAEMORRHAGE (It's was bleeding), VACCINATION SITE PAIN (it s about a size of a nickel; it s sore) and VACCINATION SITE ERYTHEMA (Little red) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 039B21A) for COVID-19 vaccination.     Concomitant products included HYDRALAZINE and ATORVASTATIN CALCIUM, EZETIMIBE (STATIN EZ) for an unknown indication.   On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 02-Apr-2021, the patient experienced BLISTER RUPTURE (The small blister burst out). On 03-Apr-2021, the patient experienced VACCINATION SITE HAEMORRHAGE (It's was bleeding). On an unknown date, the patient experienced BLISTER (One small blister and One large blister that kept growing), VACCINATION SITE PAIN (it s about a size of a nickel; it s sore) and VACCINATION SITE ERYTHEMA (Little red). At the time of the report, BLISTER (One small blister and One large blister that kept growing), BLISTER RUPTURE (The small blister burst out), VACCINATION SITE HAEMORRHAGE (It's was bleeding) and VACCINATION SITE ERYTHEMA (Little red) outcome was unknown and VACCINATION SITE PAIN (it s about a size of a nickel; it s sore) had not resolved.            Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 10-Aug-2021: Follow up received and added 2nd dose details.
Usual sore and painful arm day after vaccination.   But then an unusual reaction for me.  About the 7th day after the vaccination, an itchy red rash about 3 inches developed around the vaccination site with a moderate amount of swelling continuing.  Still have it today on the 11th day after  first dose.
COVID-19; COVID-19; Moderna, Dose Number: 1, 3 ; Pfizer/BioNTech, Dose Number: 4; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 74-year-old male patient received BNT162b2 (BNT162B2), on 11Apr2022 at 13:15 as dose 4 (booster), single (Batch/Lot number: unknown) at the age of 73 years, in left arm for covid-19 immunisation; elasomeran (MODERNA COVID-19 VACCINE), on 27Jan2021 as dose 1, single (Lot number: 037k20a), in left arm and on 26Oct2021 at 10:30 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE, also reported as "037cz1a"), on 24Feb2022 at 13:30 as dose 2, single (Lot number: 001a21a), in left arm for covid-19 immunisation. The patient's relevant medical history included: "asthma" (unspecified if ongoing); "known allergies: sulfa antibiotics" (unspecified if ongoing); "known allergies:shrimp shells" (unspecified if ongoing); "bronchitis" (unspecified if ongoing), notes: bronchitis secondary to colds and flu; "colds" (unspecified if ongoing); "flu" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: INTERCHANGE OF VACCINE PRODUCTS (medically significant) with onset 11Apr2022 at 13:15, outcome "unknown", described as "Moderna, Dose Number: 1, 3; Pfizer/BioNTech, Dose Number: 4"; DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment. Therapeutic measures were taken as a result of drug ineffective, covid-19 includes COVID 19 Treatment of PAXLOVID from 06Feb2023 to 10Feb2023.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
I experienced extreme dizziness and nausea. I could not get up from bed. Anytime I tried to get up, I would have to vomit. This went on for hours. I figured that if I had a virus, I would feel better. I never felt better. It continued for hours so my partner called an ambulance. I was admitted that night after going to Hospital ER. I was admitted for one day so they could try to control my blood pressure. The doctors ordered blood work, a MRI and a CT scan to rule things out. I was diagnosed with vertigo and I am taking blood pressure medication. As of today, I am still experiencing the effects of vertigo.